DBV Technologies | Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amarin USD 182.23M 3.71M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
DBV Technologies USD 49.48M 60K 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Galectin Therapeutics USD 14.62M 1.98M 2024-06
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
United Therapeutics USD 546.3M 19.2M 2025-09


DBV Technologies Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.